We are looking for children 2 to 17 years old to join a CD clinical trial to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or moderately to severely active ulcerative colitis (including associated symptoms such as cramping, blood in the stool, constant need to poop, frequent fevers and/or eye pain), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the UC studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child is eligible.
